National Bank Of Canada Liminal Bio Sciences Inc. Transaction History

National Bank Of Canada

  • $62.9 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023
SELL
$0.32 - $0.5 $86 - $134
-269 Reduced 0.27%
98,687 $0
Q2 2022

Jul 28, 2022
SELL
$0.44 - $0.97 $84 - $186
-192 Reduced 0.19%
98,956 $49,000
Q1 2022

May 05, 2022
BUY
$0.82 - $1.13 $16,400 - $22,601
20,001 Added 25.27%
99,148 $98,000
Q4 2021

Jan 24, 2022
BUY
$0.92 - $2.2 $72,815 - $174,123
79,147 New
79,147 $83,000

Others Institutions Holding LMNL

# of Institutions
2
Shares Held
234
Call Options Held
0
Put Options Held
0
View Full List

About Liminal BioSciences Inc.

LMNL Quotes by TradingView
  • Ticker LMNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,042,600
  • Description
  • Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...
More about LMNL
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email